Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

RESEARCH GROUPS

Oxford Haemophilia & Thrombosis Centre; NIHR Oxford Biomedical Research Centre

University of Aberdeen; Thrombosis & Haemostasis laboratory

https://www.abdn.ac.uk/people/gael.morrow1

Gael Morrow

Post-doctoral researcher

My main research interest lies in fibrinolysis and how clot structure alters the rate of lysis. I am currently working with Dr Nicola Curry and her team of clinicians at the Oxford Haemophilia and Thrombosis Centre at the Churchill Hospital. 

My work focuses on two different types of fibrinogen replacement administered to trauma patients.  Fibrinogen is the key pro-coagulant factor required for stable clot formation. Patients recruited to the Fibrinogen Early in Severe Trauma StudY (FEISTY) were given one of two treatments: cryoprecipitate or fibrinogen concentrate. My research investigates the differences in clot structure and strength between the two fibrinogens, and how this correlates with clinical outcome.


Publications

Morrow, G.B., C.S. Whyte, and N.J. Mutch, Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation. Haematologica, 2019.  Doi:10.3324/haematol.2019.230367